Biosimilars, Biologics, FDA Policy and Approvals, Clinical Trials, and Specialty Pharmacy

video_2_edelbaum-mp4

October 8, 2018October 8, 2018

Published by

Published October 8, 2018October 8, 2018

Pfizer’s Anticompetitive Suit: A Slippery Slope to Competitive Bidding? October 15, 2018
An Update From BBCIC: A Conversation With Cate Lockhart, Program Director—Part 2 October 12, 2018
Fresenius Kabi and Celltrion Get Good News October 10, 2018
An Update From BBCIC: A Conversation With Cate Lockhart, Program Director—Part 1 October 10, 2018
Celltrion’s Rituximab Biosimilar Earns Positive Review October 8, 2018
Tanvex BioPharma Files With FDA for Filgrastim Biosimilar October 4, 2018
A Momentous Decision: Momenta Reduces Its Biosimilar Footprint October 2, 2018
The Biosimilar Nocebo Effect: Is It in Patients’ Heads? October 1, 2018
Tidal Wave of Pegfilgrastim Biosimilars About to Hit Europe September 27, 2018
More From GRx+Biosims on Four-Letter Suffixes and Biosimilar Interchangeability September 20, 2018

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Email Address